HCFA Winnows Panel Agenda To Pelvic Floor Stimulation, Biofeedback
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's Interstim sacral nerve stimulation device for urinary incontinence treatment will not be reviewed as previously scheduled during the Health Care Financing Administration's Jan. 19-20 Medicare Coverage Advisory Committee meeting, agency staffers report.
You may also be interested in...
MCAC Incontinence Panel Postponed; AMA Commends MCAC Executive Cmte.
The Health Care Financing Administration will postpone the next scheduled meeting of a Medicare Coverage Advisory Committee panel following recent comments made by the MCAC Executive Committee.
MCAC Incontinence Panel Postponed; AMA Commends MCAC Executive Cmte.
The Health Care Financing Administration will postpone the next scheduled meeting of a Medicare Coverage Advisory Committee panel following recent comments made by the MCAC Executive Committee.
MCAC Med/Surg Panel Likely To Review Medicare Incontinence Policy
Pelvic floor stimulators are among the incontinence treatment modalities likely to be reviewed during the first working session of the Health Care Financing Administration's Medicare Coverage Advisory Committee medical/surgical panel, which could occur by October or November, agency staffers say.